mitomycin has been researched along with Bone Cancer in 38 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "Strontium-89 is an established alternative for the alleviation of bone pain in prostate cancer." | 9.11 | Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. ( Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R, 2005) |
| "Twenty-five patients with metastatic breast cancer in progression after prior chemotherapy +/- hormonotherapy were treated with etoposide 50 mg/m2 i." | 7.67 | Etoposide and mitomycin-C in pretreated metastatic breast cancer. ( Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D, 1989) |
| "Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 7.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
| " The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 6.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "Strontium-89 is an established alternative for the alleviation of bone pain in prostate cancer." | 5.11 | Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. ( Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R, 2005) |
| "The aim of this study was to compare the treatment efficacy of mitomycin-C plus tamoxifen (MT) to adriamycin, dibromodulcitol and tamoxifen (DAT) in previously treated patients with metastatic breast cancer." | 5.05 | A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT). ( Chang, YC; Crowley, J; Falkson, G; Tormey, DC, 1982) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Twenty-five patients with metastatic breast cancer in progression after prior chemotherapy +/- hormonotherapy were treated with etoposide 50 mg/m2 i." | 3.67 | Etoposide and mitomycin-C in pretreated metastatic breast cancer. ( Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D, 1989) |
| "Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 3.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
| " The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 2.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
| "Stage IV squamous cell carcinoma of the anus outcomes are poor, but first-line chemotherapy can enable good response rates." | 1.46 | Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience. ( Benezery, K; Cavaglione, G; Doyen, J; Evesque, L; Follana, P; François, E; Reure, J; Tuan Falk, A, 2017) |
| "Osteosarcoma is the most common malignant bone tumor in children and young people." | 1.38 | Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. ( Kallis, C; Strauss, SJ; Whelan, JS; Windsor, RE; Wood, NE, 2012) |
| "When treated with mitomycin C, p53-deficient cells, but not p53-expressing cells, showed a marked increase in ceramide levels." | 1.38 | DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells. ( Duerksen-Hughes, PJ; Filippov, V; Filippova, M; Haynes, TA; Yang, J; Zhang, K, 2012) |
| "We experienced 522 patients with breast carcinoma and 14 cases (2." | 1.29 | [A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy]. ( Matsumine, T; Matsumoto, J; Minami, T; Takami, M; Takanishi, K, 1996) |
| " In the present study we have evaluated the therapeutic efficacy of pamidronate (3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid) combined with mitomycin C (MMC) on bone metastasis of breast cancer using an animal model." | 1.29 | Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. ( Enomoto, K; Ikeda, T; Ishii, S; Kitajima, M; Tamura, H; Wada, N, 1996) |
| "Reported is the case of a hepatocellular carcinoma with a complete remission of the bone metastasis by arterial chemotherapy." | 1.28 | [Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy]. ( Aoki, Y; Fujimoto, T; Fukushima, H; Hirai, K; Iwai, I; Majima, Y; Nakashima, O; Shimada, M; Tanaka, M; Yamashita, K, 1990) |
| "A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported." | 1.27 | [Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow]. ( Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (39.47) | 18.7374 |
| 1990's | 12 (31.58) | 18.2507 |
| 2000's | 4 (10.53) | 29.6817 |
| 2010's | 5 (13.16) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Frost, MG | 1 |
| Mazloumi Aboukheili, AM | 1 |
| Toth, R | 1 |
| Walden, H | 1 |
| Evesque, L | 1 |
| Benezery, K | 1 |
| Follana, P | 1 |
| Tuan Falk, A | 1 |
| Doyen, J | 1 |
| Reure, J | 1 |
| Cavaglione, G | 1 |
| François, E | 1 |
| Oashi, K | 1 |
| Tsutsumida, A | 1 |
| Namikawa, K | 1 |
| Tanaka, R | 1 |
| Omata, W | 1 |
| Yamamoto, Y | 1 |
| Yamazaki, N | 1 |
| Lustberg, MB | 1 |
| Bekaii-Saab, T | 1 |
| Young, D | 1 |
| Otterson, G | 1 |
| Burak, W | 1 |
| Abbas, A | 1 |
| McCracken-Bussa, B | 1 |
| Lustberg, ME | 1 |
| Villalona-Calero, MA | 1 |
| Windsor, RE | 1 |
| Strauss, SJ | 1 |
| Kallis, C | 1 |
| Wood, NE | 1 |
| Whelan, JS | 1 |
| Haynes, TA | 1 |
| Filippov, V | 2 |
| Filippova, M | 2 |
| Yang, J | 1 |
| Zhang, K | 1 |
| Duerksen-Hughes, PJ | 2 |
| DAWSON, EM | 1 |
| Kornek, GV | 1 |
| Schuell, B | 1 |
| Laengle, F | 1 |
| Gruenberger, T | 1 |
| Penz, M | 1 |
| Karall, K | 1 |
| Depisch, D | 1 |
| Lang, F | 1 |
| Scheithauer, W | 1 |
| Nilsson, S | 1 |
| Strang, P | 1 |
| Ginman, C | 1 |
| Zimmermann, R | 1 |
| Edgren, M | 1 |
| Nordström, B | 1 |
| Ryberg, M | 1 |
| Kälkner, KM | 1 |
| Westlin, JE | 1 |
| Takeuchi, S | 1 |
| Akahoshi, Y | 1 |
| Kasai, C | 1 |
| Nishimoto, Y | 1 |
| Logothetis, CJ | 1 |
| Samuels, ML | 1 |
| von Eschenbach, AC | 1 |
| Trindade, A | 1 |
| Ogden, S | 1 |
| Grant, C | 1 |
| Johnson, DE | 1 |
| van Oosterom, AT | 1 |
| Powles, TJ | 1 |
| Hamersma, E | 1 |
| Smith, IE | 1 |
| Engelsman, E | 1 |
| Chang, YC | 1 |
| Falkson, G | 1 |
| Tormey, DC | 1 |
| Crowley, J | 1 |
| Moriyama, A | 1 |
| Murata, I | 1 |
| Kuroda, T | 1 |
| Yoshikawa, I | 1 |
| Tabaru, A | 1 |
| Ogami, Y | 1 |
| Otsuki, M | 1 |
| Kakinuma, H | 1 |
| Sato, K | 1 |
| Miura, K | 1 |
| Sasaki, S | 1 |
| Kato, T | 1 |
| Ishikawa, A | 1 |
| Matsuura, M | 1 |
| Nakajima, N | 1 |
| Ozawa, M | 1 |
| Matsuda, M | 1 |
| Ito, K | 1 |
| Suzuki, K | 1 |
| Toyama, K | 1 |
| Yumoto, Y | 2 |
| Okuda, T | 2 |
| Shimizu, S | 1 |
| Kawase, K | 1 |
| Matsumoto, J | 1 |
| Minami, T | 1 |
| Takami, M | 1 |
| Takanishi, K | 1 |
| Matsumine, T | 1 |
| Tamura, H | 1 |
| Ishii, S | 1 |
| Ikeda, T | 1 |
| Wada, N | 1 |
| Enomoto, K | 1 |
| Kitajima, M | 1 |
| Oura, S | 1 |
| Sakurai, T | 1 |
| Yoshimura, G | 1 |
| Tamaki, T | 1 |
| Umemura, T | 1 |
| Kokawa, Y | 1 |
| Liu, C | 1 |
| Dai, G | 1 |
| Zhang, X | 1 |
| Kokufu, I | 1 |
| Taniguchi, H | 1 |
| Kim, YH | 1 |
| Fukuda, K | 1 |
| Yamamoto, M | 1 |
| Yano, T | 1 |
| Yamada, K | 1 |
| Kitano, H | 1 |
| Huang, TG | 1 |
| Ip, SM | 1 |
| Yeung, WS | 1 |
| Ngan, HY | 1 |
| Zeng, J | 1 |
| Hu, Y | 1 |
| Pei, F | 1 |
| Lei, S | 1 |
| Mao, Y | 1 |
| Wei, Y | 1 |
| Fujii, S | 1 |
| Fukushima, H | 1 |
| Hirai, K | 1 |
| Shimada, M | 1 |
| Aoki, Y | 1 |
| Iwai, I | 1 |
| Yamashita, K | 1 |
| Fujimoto, T | 1 |
| Tanaka, M | 1 |
| Majima, Y | 1 |
| Nakashima, O | 1 |
| Thomas, G | 1 |
| Dembo, A | 1 |
| DePetrillo, A | 1 |
| Pringle, J | 1 |
| Ackerman, I | 1 |
| Bryson, P | 1 |
| Balogh, J | 1 |
| Osborne, R | 1 |
| Rosen, B | 1 |
| Fyles, A | 1 |
| Menichetti, ET | 1 |
| Silva, RR | 1 |
| Tummarello, D | 1 |
| Miseria, S | 1 |
| Torresi, U | 1 |
| Cellerino, R | 1 |
| Inoue, K | 1 |
| Horikoshi, N | 1 |
| Mukaiyama, T | 1 |
| Ogawa, M | 1 |
| Kuraishi, Y | 1 |
| Adachi, I | 1 |
| Suzuki, M | 1 |
| Tsuchihashi, T | 1 |
| Yamaguchi, K | 1 |
| Abe, K | 1 |
| Matsumoto, K | 1 |
| Sadamoto, Y | 1 |
| Haruma, K | 1 |
| Tokumo, K | 1 |
| Teshima, H | 1 |
| Murakami, S | 1 |
| Sumii, K | 1 |
| Kajiyama, G | 1 |
| Yamashita, Y | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
| Kato, Y | 1 |
| Tashima, M | 1 |
| Sawada, H | 1 |
| Yamagishi, M | 1 |
| Uchino, H | 1 |
| Sulkes, A | 1 |
| Gez, E | 1 |
| Pfeffer, MR | 1 |
| Catane, R | 1 |
| Isacson, R | 1 |
| Biran, S | 1 |
| Higashino, Y | 1 |
| Nakamura, T | 1 |
| Kato, M | 1 |
| Asano, E | 1 |
| Akimoto, R | 1 |
| Uchida, H | 1 |
| Mukawa, A | 1 |
| Nagakawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for mitomycin and Bone Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
[5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; | 1989 |
6 trials available for mitomycin and Bone Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bo | 2004 |
Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Epirubici | 2005 |
A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.
Topics: Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Mitomycin; Mitomycins; N | 1980 |
A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1982 |
31 other studies available for mitomycin and Bone Cancer
| Article | Year |
|---|---|
Characterization of FANCL variants observed in patient cancer cells.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor; Cell Surviva | 2020 |
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone | 2017 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neopla | 2014 |
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; | 2012 |
DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.
Topics: Acid Ceramidase; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Ceramides; Colonic Neop | 2012 |
OSTEOGENIC SARCOMA IN CHILDHOOD.
Topics: Adolescent; Bone Neoplasms; Child; Humans; Infant; Methotrexate; Mitomycin; Mitomycins; Neoplasms; O | 1963 |
The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.
Topics: Alternative Splicing; Antibiotics, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Colonic Neoplas | 2007 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; | 1984 |
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Ev | 1983 |
Pericardiac metastasis from advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorouracil; Heart Neoplasms; Human | 1995 |
[Chemoembolization with mitomycin C microcapsules (MMC-mc) in the treatment of bone metastases from prostatic and renal cancer].
Topics: Aged; Bone Neoplasms; Capsules; Chemoembolization, Therapeutic; Female; Humans; Kidney Neoplasms; Ma | 1994 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Ch | 1993 |
[FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intrava | 1996 |
[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Femal | 1996 |
Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Diphosphonates; | 1996 |
[Bone metastases responsive to pamidronate therapy in breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonat | 1997 |
[Chemosensitivity test for human osteosarcoma cells].
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Drug Screening Assays, Antitumor; Epirubicin; Humans; M | 1996 |
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1999 |
Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells.
Topics: Adenoviruses, Human; Antineoplastic Agents, Alkylating; Apoptosis; Bone Neoplasms; Carcinoma, Squamo | 2001 |
[Flow cytometry for testing chemosensitivity of malignant bone tumors].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neop | 1999 |
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubi | 1992 |
[Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy].
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Ne | 1990 |
Concurrent radiation and chemotherapy in vulvar carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
Etoposide and mitomycin-C in pretreated metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Etopo | 1989 |
[Bone metastasis in advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Cyclop | 1987 |
[Bone metastasis from renal cell carcinoma].
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Humans; Kidney Neoplasms; Mitomyci | 1987 |
[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 1987 |
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Com | 1988 |
[A cancer of unknown primary site with diffuse metastasis to the bone marrow treated effectively with FAM combination chemotherapy].
Topics: Anemia, Myelophthisic; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1988 |
Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Breast Neo | 1986 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1985 |